Company / FCF Margin
C4 Therapeutics, Inc. FCF Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-276.2%
FY2025
5-year range
-523.0% / -192.7%
FY2022-FY2025
Trend
+47.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -523.0% to -276.2% over the past 2 years.
Based on SEC 10-K filings.
-276.2% in FY2025 with a 3-year CAGR of -83.5%.
Improved from -523.0% to -276.2% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -83.5pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin increased 47.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -276.2% | +47.2% |
| FY2024 | -523.0% | +0.0% |
| FY2023 | -523.0% | -171.3% |
| FY2022 | -192.7% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026